Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Monday, November 29, 2021

Lucintel Forecasts Biotherapeutics Cell Line Development Market to Grow at a CAGR of 6%-8%

According to the recent study the biotherapeutics cell line development market is projected to grow at a CAGR of 6%-8% from 2020 to 2026. Growth in this market is primarily driven by increase in geriatric population and prevalence of diseases, government initiatives to boost biotechnology & pharmaceutical sectors, and development of advanced technologies to cater to the rising demand for monoclonal antibodies.

Browse XX figures / charts and XXtables in this 150-page report to understand trends, opportunities and forecast in biotherapeuticscell line developmentmarketby process (transfection & selection and single cell cloning and consumable), CLD option (in-house, outsourced, do-it-yourself, and hybrid), and region (North America, Europe, Asia Pacific, and Rest of the World).

Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/biotherapeutics-cell-line-development-market.aspx

“Transfection & selection and single cell cloning market is expected to remain the largest segment during the forecast period.”

Based on process, the biotherapeutics cell line development market is segmented intotransfection & selection and single cell cloning and consumable. Lucintel forecasts that the transfection & selection and single cell cloning market is expected to remain the largest segment during the forecast perioddue to rise in demand for biotherapeutics, increase in adoption of instruments, such as FACS (Fluorescence-Activated Cell Sorting) &ClonePix, and higher throughput nature of this method.

“Within the biotherapeutics cell line development market, the outsource segment is expected to remain the largest CLD Option.”

Based on CLD Option, the outsource segment is expected to witness the largest segment over the forecast period due to increase in demand for outsourced products, cost saving, and rapid delivery of products are some of the major factors that drive the outsource segment.

“North America will dominate the biotherapeutics cell line development market in near future.”

North America is expected to be the largest region over the forecast period due to high funding in new biological drugs, rise in geriatric population, increase in prevalence of various diseases in the developed countries of the region, and growth in government funding for research and development activities.

Download Brochure of this report by clicking on https://www.lucintel.com/biotherapeutics-cell-line-development-market.aspx

Major players of biotherapeutics cell line development market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Merck KGaA, Becton, Dickinson and Company (BD), Danaher, BoehringerIngelheim Group, Thermo Fisher Scientific, Lonza Group, Probiogen, Solentim, Selexis, and Sysmexare among the major biotherapeutics cell line development providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/biotherapeutics-cell-line-development-market.aspxor or helpdesk@lucintel.com.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com.

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email:
brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751

Related reports

Surgical Instrument Tracking System Market:

For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

 

Metabolomics Market:

For more details click here https://www.lucintel.com/metabolomics-market.aspx

 

Industrial Microbiology Market:

For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

 

Surgical Microscope Market:

For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

 

Tumor Ablation Market:

For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

 

Vitamin D Market:

For more details click here https://www.lucintel.com/vitamin-d-market.aspx

 

Urology Device Market:

For more details click here https://www.lucintel.com/urology-device-market.aspx

 

Halal Ingredient Market:

For more details click here https://www.lucintel.com/halal-ingredient-market.aspx

 

Gene Expression Market:

For more details click here https://www.lucintel.com/gene-expression-market.aspx

 

GMO Testing Market:

For more details click here https://www.lucintel.com/gmo-testing-market.aspx

No comments:

Post a Comment